AU2001274251A1 - Novel pharmaceutical formulation suitable for nebulisation - Google Patents

Novel pharmaceutical formulation suitable for nebulisation

Info

Publication number
AU2001274251A1
AU2001274251A1 AU2001274251A AU7425101A AU2001274251A1 AU 2001274251 A1 AU2001274251 A1 AU 2001274251A1 AU 2001274251 A AU2001274251 A AU 2001274251A AU 7425101 A AU7425101 A AU 7425101A AU 2001274251 A1 AU2001274251 A1 AU 2001274251A1
Authority
AU
Australia
Prior art keywords
nebulisation
pharmaceutical formulation
formulation suitable
novel pharmaceutical
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001274251A
Inventor
Duncan Robert Armour
David Brown
Miles Stuart Congreve
Paul Martin Gore
Darren Victor Stev Green
Stuart Holman
Torquil Iain Macle Jack
Andrew Mcmurtrie Mason
Karen Morriss
Nigel Grahame Ramsden
Marian Thomas
Peter Ward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2001274251A1 publication Critical patent/AU2001274251A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
AU2001274251A 2000-06-16 2001-06-15 Novel pharmaceutical formulation suitable for nebulisation Abandoned AU2001274251A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0014883 2000-06-16
GBGB0014883.3A GB0014883D0 (en) 2000-06-16 2000-06-16 Novel pharmaceutical formulation
PCT/GB2001/002688 WO2001095880A1 (en) 2000-06-16 2001-06-15 Novel pharmaceutical formulation suitable for nebulisation

Publications (1)

Publication Number Publication Date
AU2001274251A1 true AU2001274251A1 (en) 2001-12-24

Family

ID=9893884

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001274251A Abandoned AU2001274251A1 (en) 2000-06-16 2001-06-15 Novel pharmaceutical formulation suitable for nebulisation

Country Status (6)

Country Link
US (1) US20040034058A1 (en)
EP (1) EP1289498A1 (en)
JP (1) JP2004503487A (en)
AU (1) AU2001274251A1 (en)
GB (1) GB0014883D0 (en)
WO (1) WO2001095880A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
US11246957B2 (en) * 2015-07-28 2022-02-15 Newmedical Technology, Inc. Systems and methods for making hydrophilic foams
CN107137518A (en) * 2016-03-01 2017-09-08 北京盈科瑞药物研究院有限公司 A kind of 'Zhichuanling Neulized inhalation pharmaceutical solutions and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9828074D0 (en) * 1998-12-18 1999-02-17 Glaxo Group Ltd Therapeutically useful compounds
GB9924415D0 (en) * 1999-10-16 1999-12-15 Glaxo Group Ltd Medicament pack

Also Published As

Publication number Publication date
WO2001095880A1 (en) 2001-12-20
GB0014883D0 (en) 2000-08-09
US20040034058A1 (en) 2004-02-19
EP1289498A1 (en) 2003-03-12
JP2004503487A (en) 2004-02-05

Similar Documents

Publication Publication Date Title
AU781269C (en) Pharmaceutical compositions
AU1928501A (en) Formulations for pharmaceutical agents ionizable as free acids or free bases
AU2001250420A1 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
AU2002257582A1 (en) Pharmaceutical formulation
AU2002302147A1 (en) Pharmaceutical composition
AU3556400A (en) Pharmaceutical compositions
AU4328800A (en) Pharmaceutical formulation
AU6715600A (en) Pharmaceutical formulations
AU2001273919A1 (en) Pharmaceutical compositions
AU6460400A (en) Pharmaceutical compositions
AU4977300A (en) Pharmaceutical formulations
AU1141101A (en) Pharmaceutical aerosol formulations comprising s-salmeterol
AU6460200A (en) Pharmaceutical compositions
AU4085201A (en) Pharmaceutical composition
AU2001260089A1 (en) Pharmaceutical compositions comprising desglymidodrine as an active drug substance
AU3839900A (en) Pharmaceutical formulation
AU2001274251A1 (en) Novel pharmaceutical formulation suitable for nebulisation
AU6460100A (en) Pharmaceutical compositions
AU6460300A (en) Pharmaceutical compositions
AU1388501A (en) Pharmaceutical formulation
AU2001264145A1 (en) Novel pharmaceutical formulation suitable for nebulisation
AU3586401A (en) Pharmaceutical composition
AU2001278705A1 (en) Pharmaceutical composition
AU2001264129A1 (en) Novel aqueous anti-inflammatory pharmaceutical formulation